Exceeding the guideline-recommended maximum daily dose of opioids for long-term treatment of non-cancer pain in Germany – a large retrospective observational study.

MLA

Schrader, Nils Frederik, et al. “Exceeding the Guideline-Recommended Maximum Daily Dose of Opioids for Long-Term Treatment of Non-Cancer Pain in Germany – a Large Retrospective Observational Study.” BMC Public Health, vol. 24, no. 1, Sept. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12889-024-20141-4.

APA

Schrader, N. F., Niemann, A., Weitzel, M., Speckemeier, C., Abels, C., Blase, N., Giebel, G. D., Riederer, C., Nadstawek, J., Straßmeir, W., Wasem, J., & Neusser, S. (2024). Exceeding the guideline-recommended maximum daily dose of opioids for long-term treatment of non-cancer pain in Germany – a large retrospective observational study. BMC Public Health, 24(1), 1–13. https://doi.org/10.1186/s12889-024-20141-4

Chicago

Schrader, Nils Frederik, Anja Niemann, Milena Weitzel, Christian Speckemeier, Carina Abels, Nikola Blase, Godwin Denk Giebel, et al. 2024. “Exceeding the Guideline-Recommended Maximum Daily Dose of Opioids for Long-Term Treatment of Non-Cancer Pain in Germany – a Large Retrospective Observational Study.” BMC Public Health 24 (1): 1–13. doi:10.1186/s12889-024-20141-4.